LMR Partners’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-43,921
Closed -$145K 607
2016
Q2
$145K Buy
+43,921
New +$166K 0.02% 375

Other funds holding ARLZ

LMR Partners's ARLZ Position: Q3 2016 in Review

LMR Partners sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2016, closing a stake of 43,921 shares — an estimated $145K sold.

LMR Partners first reported a position in ARLZ in Q2 2016 and held it in 1 quarter. The position peaked at $145K in Q2 2016. 83 funds tracked by Wall St. Rank hold ARLZ as of Q3 2016.

  • LMR Partners reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2016 after selling out during the quarter.
  • LMR Partners sold 43,921 Aralez Pharmaceuticals Inc. shares in Q3 2016, an estimated $145K.
  • LMR Partners first reported a position in Aralez Pharmaceuticals Inc. in Q2 2016 and held it in 1 quarter.
  • LMR Partners's Aralez Pharmaceuticals Inc. position peaked at $145K in Q2 2016.
  • 83 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2016.

Based on LMR Partners's 13F filing for Q3 2016, filed 1 Nov 2016.